[go: up one dir, main page]

NO20073288L - Gram-positive rekombinant protein-produserende bakterier - Google Patents

Gram-positive rekombinant protein-produserende bakterier

Info

Publication number
NO20073288L
NO20073288L NO20073288A NO20073288A NO20073288L NO 20073288 L NO20073288 L NO 20073288L NO 20073288 A NO20073288 A NO 20073288A NO 20073288 A NO20073288 A NO 20073288A NO 20073288 L NO20073288 L NO 20073288L
Authority
NO
Norway
Prior art keywords
fbfp
useful
gram
nucleic acids
recombinant protein
Prior art date
Application number
NO20073288A
Other languages
English (en)
Inventor
Eldie Berger
Maureean Elisabeth Louw
Michael Craig Crampton
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Publication of NO20073288L publication Critical patent/NO20073288L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/20—Heavy metals or heavy metal compounds
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00—Biological treatment of water, waste water, or sewage
    • C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Water Treatment By Sorption (AREA)

Abstract

Oppfinnelsen tilveiebringer flagellin-baserte fusjonsproteiner (FBFP) som er anvendbare for en rekke formål, nukleinsyrer som koder for FBFP, vektorer som inneholder nukleinsyrene, og vertsceller som huser vektorene. Videre tilveiebringer oppfinnelsen fremgangsmåter for å oppnå overekspresjon og overflatefremvisning av heterologe polypeptider i Gram-positive bakterieceller. I tillegg vedrører oppfinnelsen genforstyrrede bakterier som er anvendbare for ekspresjon av rekombinant FBFP på deres overflater. Oppfinnelsen vedrører også genetiske konstrukter som er anvendbare for å fremstille FBFP og fremgangsmåter for å anvende FBFP.
NO20073288A 2004-12-02 2007-06-26 Gram-positive rekombinant protein-produserende bakterier NO20073288L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200409786 2004-12-02
PCT/IB2005/054022 WO2006072845A2 (en) 2004-12-02 2005-12-02 Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid

Publications (1)

Publication Number Publication Date
NO20073288L true NO20073288L (no) 2007-08-16

Family

ID=36586075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073288A NO20073288L (no) 2004-12-02 2007-06-26 Gram-positive rekombinant protein-produserende bakterier

Country Status (12)

Country Link
US (1) US7888064B2 (no)
EP (1) EP1836221B1 (no)
JP (1) JP2008521431A (no)
CN (1) CN101128480A (no)
AT (1) ATE518881T1 (no)
AU (1) AU2005323811B2 (no)
BR (1) BRPI0515748A (no)
CA (1) CA2588871A1 (no)
NO (1) NO20073288L (no)
RU (1) RU2007124731A (no)
WO (1) WO2006072845A2 (no)
ZA (1) ZA200704489B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827489B1 (en) * 2004-12-16 2012-10-31 Wake Forest University Health Sciences Use of flagellin in tumor immunotherapy
US20100285532A1 (en) 2008-01-08 2010-11-11 Eldie Berger Production of heterologous proteins or peptides
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
FR2949459B1 (fr) * 2009-08-28 2014-10-17 Otv Sa Agent de prevention et/ou de lutte contre le moussage biologique
US8759044B2 (en) 2011-03-23 2014-06-24 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
US8765425B2 (en) 2011-03-23 2014-07-01 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
JP5943463B2 (ja) * 2012-03-05 2016-07-05 国立大学法人神戸大学 レアメタル結合能を有する人工ペプチドおよびその利用
CN103031328B (zh) * 2012-11-22 2015-08-05 江南大学 利用一种融合标签提高外源蛋白质的表达量
JP2015100764A (ja) * 2013-11-26 2015-06-04 株式会社東芝 汚泥処理装置、及び汚泥処理方法
JP6377552B2 (ja) * 2015-03-13 2018-08-22 株式会社東芝 汚泥処理システム
JP6377553B2 (ja) * 2015-03-13 2018-08-22 株式会社東芝 汚泥処理システム
JP6591224B2 (ja) * 2015-07-23 2019-10-16 株式会社東芝 処理装置及び処理方法
US10849938B2 (en) 2017-09-13 2020-12-01 ZBiotics Company Gene expression system for probiotic microorganisms
CN108060171B (zh) * 2017-12-27 2020-11-06 中南大学 一种表面展示金属结合蛋白基因及其在回收铂钯金属中的应用
JP7558167B2 (ja) 2018-12-03 2024-09-30 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム オリゴベンズアミド類似体およびがん処置におけるそれらの使用
CN111249444B (zh) * 2020-03-10 2023-04-07 西北大学 一种用于抑制白色念珠菌的制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002385A1 (en) 1985-10-11 1987-04-23 Genetics Institute, Inc. Method for producing heterologous proteins
US4886748A (en) 1986-03-11 1989-12-12 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same
CA1340817C (en) 1988-05-05 1999-11-09 Salete Maria Cardozo Newton Recombinant flagellin vaccines
ES2176082B1 (es) 2000-05-31 2004-01-01 Consejo Superior Investigacion Bacterias con la capacidad de unir metales pesados y su empleo en la detoxificacion de medios contaminados con metales pesados.
WO2003011487A1 (en) * 2001-07-27 2003-02-13 Global Biosciences, Inc. Remediation of metal contaminants with hydrocarbon-utilizing bacteria
US20060035223A1 (en) * 2002-03-13 2006-02-16 Naik Rajesh R Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby
DE10220094B4 (de) 2002-05-04 2004-02-26 Ontoprise Gmbh Datenverarbeitungssystem
CN1659187A (zh) * 2002-05-10 2005-08-24 新世纪药品有限公司 融合铁蛋白在疫苗和其他方面的应用
JP2006181393A (ja) 2003-03-10 2006-07-13 Ip Bio Corp ノンスラッジ高速排水処理システム
ES2438190T3 (es) 2003-07-30 2014-01-16 Japan Science And Technology Agency Péptido susceptible de unirse a titanio, plata y silicona

Also Published As

Publication number Publication date
ZA200704489B (en) 2008-11-26
WO2006072845A3 (en) 2007-03-01
JP2008521431A (ja) 2008-06-26
EP1836221A2 (en) 2007-09-26
AU2005323811B2 (en) 2012-07-05
EP1836221B1 (en) 2011-08-03
CA2588871A1 (en) 2006-07-13
ATE518881T1 (de) 2011-08-15
AU2005323811A1 (en) 2006-07-13
CN101128480A (zh) 2008-02-20
WO2006072845A2 (en) 2006-07-13
US20080003237A1 (en) 2008-01-03
BRPI0515748A (pt) 2008-08-05
US7888064B2 (en) 2011-02-15
RU2007124731A (ru) 2009-01-10

Similar Documents

Publication Publication Date Title
NO20073288L (no) Gram-positive rekombinant protein-produserende bakterier
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
Yang et al. Generation of an artificial double promoter for protein expression in Bacillus subtilis through a promoter trap system
ZA202304237B (en) Dna modifying enzymes and active fragments and variants thereof and methods of use
WO2020139783A3 (en) Polypeptides useful for gene editing and methods of use
DK2048236T3 (da) Genekspressionsteknik
WO2009011258A1 (ja) 外来遺伝子を細胞に安定に保持する方法
KR20170085129A (ko) 펩티드 생산용 융합 파트너
DK1410023T3 (da) Fremgangsmåder til anvendelse af 06-alkylguanin-DNA-alkyltransferaser
WO2007064437A3 (en) Methods for production of receptor and ligand isoforms
EP1601766A4 (en) METHODS OF CONSTRUCTING BANK OF BIODIVERS GENE FRAGMENTS AND BIOLOGICAL MODULATORS ISOLATED THEREFROM
WO2004096992A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
WO2006137836A3 (en) Bacterial vector systems
DK2460823T3 (da) Modificeret sekretionssystem til øget ekspression af polypeptider ibakterier
WO2009080299A8 (en) Sm-protein based secretion engineering
Wu et al. Cloning and analysis of WF146 protease, a novel thermophilic subtilisin-like protease with four inserted surface loops
EP1847611A3 (en) Rhamnose-inducible expression system
WO2005081959A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefor
DK1630232T3 (da) Optimerede nukleotidsekvenser kodende for sgp130
DE502004006718D1 (de) Ein translokationsenzym als selektionsmarker
Kouwen et al. Contributions of the pre-and pro-regions of a Staphylococcus hyicus lipase to secretion of a heterologous protein by Bacillus subtilis
ATE451457T1 (de) Verfahren zur dipeptidherstellung
WO2001032872A3 (en) Twik potassium channel molecules and uses therefor
DE602004004796D1 (de) Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
ATE268820T1 (de) Herstellung von heterloge proteine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application